Skip to content

Breast Cancer Clinical Trials

Breast Cancer

Learn More About Breast Cancer

For general information on breast cancer (including risk factors, symptoms, diagnosis, and treatment) visit the Cancer Council’s website:

Read More

General Enquiries

For general questions about trial availability, eligibility, or the referral process, please contact us using the form below. Our team will respond as soon as possible.

Enquiry Form
Protocol NumberCancer TypeStudy NameInterventionMechanism of ActionRecruitment StatusSponsorClinicalTrials.gov IDClick to Enquire
PTT-4256-01Breast CancerA Modular, Open Label, Dose Finding, Phase 1/2 Clinical Trial in Patients With Solid Tumours to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of PTT-4256ImmunotherapyInhibitor of the pH-sensing G-protein-coupled receptor 65Open - RecruitingPathios Therapeutics Pty LtdNCT06634849Enquire Now
DM002001Breast CancerA Phase I, Multicentre, Open-label, First-in-Human, Dose Escalation and Expansion Study of DM002 in Patients With Advanced Solid TumorsAntibody Drug ConjugateADC targeting MUC1 and HER3Open - RecruitingXadcera Biopharmaceutical (Suzhou) Co., Ltd.NCT06751329Enquire Now
SR-8541A-001Breast CancerPhase 1, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of SR-8541A (ENPP1 Inhibitor) Administered Orally as Monotherapy or in Combination With Checkpoint Inhibitors in Subjects With Advanced/Metastatic Solid TumorsTargetedENPP1 inhibitorOpen - RecruitingStingray TherapeuticsNCT06063681Enquire Now
SRG-514-01Breast CancerA Phase 1 Study of SRG-514 Administered Intraoperatively to the Site of Tumor Resection of Patients Undergoing Breast-Conserving Cancer SurgeryNSAID GelIntraoperative administration into breast cavity. Newly diagnosed BCa patients. Gel Ketorolac (NSAID by blocking cyclooxygenase (COX) enzymes).Open - RecruitingSURGE TherapeuticsNCT06300411Enquire Now